9 February 2023 - A genetic test to establish if a newborn baby is vulnerable to deafness if treated with a commonly used antibiotic has been recommended by NICE in draft guidance.

The assessment of the genedrive kit has been carried out through NICE’s Early Value Assessment pilot project which has been created to enable earlier access to digital products, medical devices and diagnostics that address national unmet needs in health and social care.

Read NICE press release